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Objective: This retrospective study aimed to investigate the types and distribution of neoplasm of salivary glands 
in a Turkish population. 
Study Design: The histological diagnosis records of the Department of Pathology at Cumhuriyet University were 
reevaluated for 125 patients who were treated for salivary gland tumors from 1987 to 2008. The neoplasms were 
analyzed for histological diagnosis, age, sex, and site. The histological diagnoses were analyzed according to the 
2005 WHO classification.
Results: A total of 125 primary salivary gland neoplasms, consisting of 95 (76%) benign and 30 (24%) malignant 
groups were recorded. The most common major and minor salivary gland sites were the parotid (61.6%) and pala-
tal glands (9.6%), respectively. Pleomorphic adenoma was the most frequent benign tumor followed by Warthin’s 
tumor. Among the malignant group, adenoid cystic carcinoma was the most prevalent. Age for all cases ranged 
from 16-80 years; mean age was 41.97 years, with a female to male ratio of 1:1.15. 
Conclusions: Although there were some discrepancies, the characteristics of salivary gland tumors of Turkish 
patients are in line with those of patients from other countries according to tumor type, tumor site distribution, 
and age and sex of patients. 
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Introduction
Salivary gland tumors are specific neoplasms in the oral 
and maxillo-facial area. However, morphological het-
erogeneity and low frequency make it considerably dif-
ficult to histologically classify these tumors (1,2). The 
frequency of salivary gland neoplasms varies from 0.4 
to 13.5 annual cases per 100 000 inhabitants in various 
populations. Of all diagnosed neoplasms, salivary gland 
tumors constitute 3% of those in the head and neck area 
(3).
Salivary gland tumors are more frequent in adults than 
in children (4). Among all salivary gland tumors, the 
most frequently reported benign tumor is pleomorphic 
adenoma (1,3-15). Considering the malignant salivary 
gland neoplasms, reports of the most commonly seen tu-
mor varies but, in general, mucoepidermoid carcinoma 
(7,8,11,15-17) and adenoid cystic carcinoma (5,6,9,12,18) 
were reported. 
While tumors of the salivary glands can appear at any 
age, the maximum incidences is in the fourth decade of 
life for benign lesions and in the fifth decade for ma-
lignant tumors, although different authors consider the 
peak incidence correspond to the period between the 
fifth and seventh decades of life. Classically, these le-
sions have been reported to be more frequent in women, 
although the proportion varies according to the histo-
logical type of tumor (10).
Despite vast literature (1,3-18) reporting the prevalence 
of salivary gland tumors in patients from different 
countries, no substantial reports of these tumors was 
encountered among Turkish population. In addition to 
ethnicity and geographic location, the large variations 
also included the impact of different methods of regis-
tration (1).
The present study aimed to analyze the incidence and 
distribution of salivary gland tumors in a Turkish se-
ries, and provides data for comparison with previously 
published epidemiological studies from different geo-
graphical sites. Demographic data from these studies 
are vital for better understanding of the biological and 
clinical characteristics of the disease. 
Patients and methods
This study covered the Department of Oral and Maxil-
lofacial Surgery, Department of Otorhinolaryngology 
and Head and Neck Surgery of Cumhuriyet University 
and two different government hospitals’ salivary gland 
neoplasm cases. During a 21-year period (1987-2008), 
125 adult patients with primary neoplasm of the sali-
vary gland were analyzed at the Pathology Department 
of Cumhuriyet University. The clinical and histopatho-
logical records were reviewed by the authors in consul-
tation with a pathologist.
The major salivary glands involved the parotid gland, 
submandibular gland, and sublingual gland, whereas 
the minor glands included those in lip and intra-oral re-
gions (the palate, lip, buccal cavity, floor of the mouth, 
and maxillary region). 
The data were evaluated for all patients with surgically 
removed or biopsied pathologies of the salivary gland. 
All data were examined regarding histological diagno-
sis, age, sex, and site from which the biopsy was taken. 
The histological specimens were reviewed by a patholo-
gist and ranked according to the WHO Classification 
of 2005. 
Due to the nature of the study, little clinical informa-
tion was available and therefore was not included in this 
study. Tumorlike lesions such as benign lymphoepi-
thelial lesion, lymphoepithelial cyst, mucocele, ranula, 
salivary duct cyst, sarcoidosis, and sialidosis were ex-
cluded from the study. 
Results
- Age and gender distribution
A total of 125 patients suffering from primary salivary 
gland neoplasm were identified, including 66 males, 57 
females and 2 unclassified (Table 1). These data gave a 
ratio for female-to-male of 1:1.15. The patients’ median 
age at the time of diagnosis was 41.97 with a range of 
16-80 years. The peak occurrence of tumors was in the 
second decade for males and fifth for females. The aver-
age age of patients with benign tumor was 40.05 with 
a wide range from 16 to 75 years and peak incidence 
was between the second and fifth decades of life. The 
average age of patients with malignant tumor was 48.08 
years of age with a wide range from 20 to 80 and peak 
incidence was between third and fifth decades of life 
(Table 1).
- Anatomic location of the tumors
In this study, all of the salivary gland tumors occurred uni-
laterally. The site distribution was as follows: 77 parotid 
glands, 20 submandibular glands, and 25 minor salivary 
gland tumors (Table 2). Locations of 3 of the tumors were 
not identified. There was no case of sublingual gland tu-
mor. The palate 12 (48%) was the most commonly affected 
site among the minor salivary gland tumors.  
The parotid gland was the most common site of benign 
tumor involvement (67.3%), followed by the subman-
dibular gland (16.8%), and the minor salivary gland 
(15.7%). Benign minor salivary gland tumors showed 
a distinct predilection for the palate (66.6%) followed 
by the lips (26.6%), whereas they were rare in other re-
gions (6.6%). In the minor salivary glands, benign tu-
mors (60%) were more frequent than malignant tumors 
(40%) (Table 2). 
The parotid gland (43.3%) was also the main site of 
occurrence of malignant tumors, followed by the mi-
nor salivary gland (33.3%) and submandibular gland 
(%13.3). The maxilla (50%) was the most frequent site 
of the malignant minor salivary gland tumors.  
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Of all the parotid gland neoplasms, pleomorphic ade-
noma was the most frequent tumor, constituting 68.8%. 
The most frequent malignant tumor was adenoid cystic 
carcinoma (5.2%) (Table 2). In the submandibular gland, 
the most frequent benign tumor was the pleomorphic 
adenoma (60%). There were only four (20%) malignant 
tumor occurrences seen in this area and each of these 
was different from the others according to histological 
type. In the minor salivary glands, the most frequent be-
nign and malignant tumors were pleomorphic adenoma 
(60%) and adenoid cystic carcinoma (20%), respectively 
(Table 2).  
- Tumor type
The overall frequency of benign tumors and malignant 
tumors was 76% and 24%, respectively (Table 1). Pleo-
morphic adenoma was the most common type of tumor 
and constituted 84.2% of benign tumors and 64% of all 
tumors. Among the malignant salivary neoplasms, ad-
enoid cystic carcinoma was the most prevalent at 36.6% 
of malignant tumors and 8.8% of all tumors, followed 
by adenocarcinoma not otherwise specified not other-
wise specified (NOS) at 16.6% of malignant tumors and 
4% of all tumors (Table 1). 









Pleomorphic adenoma 36 43 1 38.64 16-75 80 64 84.2
Warthin’s tumor 6 0 52.6 43-67 6 4.8 6.3
Hemangioma 2 1 29.6 20-36 3 2.4 3.1
Myoepithelioma 2 0 58 47-69 2 1.6 2.1
Cystadenoma 0 2 41 41 2 1.6 2.1
Basal cell adenoma 1 0 74 74 1 0.8 1.0
Lipoma 1 0 36 36 1 0.8 1.0
Total 48 46 1 40.05 16-75 95 76 100
Malignant tumors
Adenoid cystic carcinoma 8 3 46.5 20-68 11 8.8 36.6
Adenocarcinoma NOS 3 2 39 30-49 5 4 16.6
Mucoepidermoid carci-
noma 2 1 42 23-63 3 2.4 10.0
Carcinoma ex-pleomor-
phic adenoma 1 1 21 21 2 1.6 6.6
Adenosquamous carci-
noma 2 0 65.5 61-70 2 1.6 6.6
Squamous cell carcinoma 0 2 58 36-70 2 1.6 6.6
Undifferantiated carci-
noma 1 1 69 58-80 2 1.6 6.6
Polimorphous low grade 
adenocarcinoma 0 0 1 - - 1 0.8 3.3
Salivary duct carcinoma 1 0 33 33 1 0.8 3.3
Acinic cell carcinoma 0 1 71 71 1 0.8 3.3
Total 18 11 1 48.08 20-80 30 24 100
Table 1. Age, gender, and diagnosis distribution of salivary gland neoplasm.
NOS: not otherwise specified
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Discussion
Salivary glands tumors are specific in the oral and max-
illofacial region, corresponding to approximately 3% 
to 10% of neoplasms of this area (11). Although demo-
graphic data from these studies makes understandable 
the biological and clinical characteristics of the disease 
(6), the lack of a nation-wide population-based neo-
plasm registry was encountered in Turkey, which makes 
it impossible to give any prevalence values for salivary 
gland neoplasms in this country. This study provides 
data for comparison with other epidemiological studies 
from different geographical sites and races.
During 1987–2008, 125 patients with salivary gland tu-
mors were diagnosed and treated in this hospital; almost 
all of them received surgical treatment. In the primary 
tumors, the benign: malignant ratio was 3.16:1. The ra-
tios from similar studies in other countries ranged from 
1.34:1 in China (1), 1.6:1 in India (6), 2.33:1 in Jordan 
(9), 4:1 in Brazil (11), and 5.36:1 in the US (15).
Pleomorphic adenoma was the most commonly en-
countered type of salivary gland neoplasm, which is in 
 Salivary gland  
 Major Minor  
Benign tumors Parotid % SM % Palate Lip Buccal Maxillary Floor of the mouth Total % Unknown
Grand 
total %
Pleomorphic adenoma 53 68.8 12 60 10 4 1 15 60 80 64 
Warthin's tumor 5 6.5 1 5    6 4.8 
Hemangioma 2 2.6 1 5       3 2.4 
Cystadenoma   2 10       2 1.6 
Myoepithelioma 2 2.6      2 1.6 
Basal cell adenoma 1 1.3      1 0.8 
Lipoma 1 1.3         1 0.8 
Total 64 83.1 16 80 10 4 1   15 60  95 76 
Malignant tumors              
Adenoid cystic 
carcinoma 4 5.2 1 5 1 1  2 1 5 20 1 11 8.8 
Adenocarcinoma NOS 2 2.6      2  2 8 1 5 4 
Mucoepidermoid 
carcinoma 1 1.3 1 5    1  1 4  3 2.4 
Carcinoma
expleomorphic adenoma 1 1.3 1 8.3 1     1 4  2 1.6 
Adenosquamous
carcinoma 1 1.3    1    1 4  2 1.6 
Squamous cell carcinoma 1 1.3 1 1.2       2 1.6 
Undifferantiated 
carcinoma 2           2 1.6 
Polimorphous low grade 
adenocarcinoma           1 1 0.8 
Salivary duct carcinoma   1 5        1 0.8 
Acinic cell carcinoma 1 1.3          1 0.8 
Total 13 16.9 4 20 2 2  5 1 10 40 3 30 24 
Grand Total 77 100 20 100 12 6 1 5 1 25 100 100 125 100 
Table 2. Histological diagnosis and site distribution of salivary gland neoplasms (n=125).
agreement with findings from all of the published lit-
erature from all over world (1,3-15). The incidence of 
pleomorphic adenoma has been reported to range from 
between 40.8% and 70% (9). Of all the lesions, pleomor-
phic adenoma constituted 64% followed by Warthin’s 
tumor 4.8%, and then hemangioma at 2.4%. The report 
according to the prevalence of malignant salivary gland 
tumor was various. Some authors (7,8,11,15-17) have 
reported that mucoepidermoid carcinoma is the most 
frequent malignant salivary tumor.  In contrast to these 
studies, in the present study, adenoid cystic carcinoma 
was the most frequent malignant tumor found, which 
corroborates reports by Toida et al. (5), Subhashraj (6), 
Al-Khateeb et al. (9), Kamulegeya et al. (12), and Ra-
pidis et al. (18). 
Of all salivary gland tumors included in this study, 
61.6% were located in the parotid gland, 16% in the 
submandibular gland, 20% in the minor salivary glands 
and 2.4% were unknown. This result is similar to find-
ings of most of the published reports (1,6,9). However, 
according to Vargas’s et al. (11) report, the submandibu-
NOS: not otherwise specified
Med Oral Patol Oral Cir Bucal. 2010 Nov 1;15 (6):e880-5.                                                                                                                                                                Neoplasms of the salivary glands
e884
lar gland is the most frequent, affecting other areas than 
minor salivary glands. Furthermore, Kamulegeya et al. 
(12) reports that the palate is the most commonly af-
fected area of the salivary gland tumors. Of the minor 
salivary gland sites, the palate was the most frequently 
affected. This is consistent with previously reported 
studies (1,3-18). 
In almost all published studies, the parotid gland was 
the predominant area of the benign tumors (1,3-20), with 
which we agree (83.1%). The present study also con-
firms previous reports that the pleomorphic adenomas 
(68.8%) are more frequently seen than any other group 
of parotid gland’s tumors. Although there is no consen-
sus in the literature according to parotid gland malig-
nancies, the majority of reports found that mucoepi-
dermoid carcinoma is the most frequent parotid gland 
malignancy (1,6,11,15). According to Al-Khateeb’s et al. 
(9) report, the frequency of mucoepidermoid carcinoma 
and adenoid cystic carcinoma originating from the pa-
rotid gland was equal. On the other hand, other series 
have reported adenoid cystic carcinoma (12), carcinoma 
ex pleomorphic adenoma (19), squamous cell carcinoma 
(8), and acinic cell carcinoma (20) as the most common 
parotid gland malignancy. In contrast to the literature, 
in this study, the most frequent malignant tumor in the 
parotid gland was adenoid cystic carcinoma (5.2%).
In the submandibular gland, we found that the most 
common benign tumor was pleomorphic adenoma, 
which is consistent with the all of the previously pub-
lished reports (8,11,12). On the other hand, there are 
small numbers of malignant salivary tumors affecting 
the submandibular gland. In this series, only three ma-
lignant cases were seen in this area, including adenoid 
cystic carcinoma, mucoepidermoid carcinoma, and sali-
vary duct carcinoma. The literature shows that adenoid 
cystic carcinoma is the most frequent malignant tumor 
of the submandibular gland (1,6,9).
Pleomorphic adenoma (60%) was the most frequent 
tumor of the minor salivary glands, in agreement with 
the literature (1,3-15). Adenoid cystic carcinoma (20%) 
was the most commonly encountered malignant tumor 
in the minor salivary glands. Although a great number 
of reports (1,5,6,8,9) corroborate our study, according to 
some reports (7,11), mucoepidermoid carcinomas were 
the most common malignant minor salivary gland tu-
mors. In contrast to other studies, van Heerden et al. 
(14) reported that polymorphous low-grade adenocar-
cinoma was the most common malignant tumor. In this 
study, no cases of sublingual gland tumors were found. 
This confirms the rarity of salivary tumors at this site. 
The average age at the time of diagnosis for salivary 
gland neoplasms was 41.97 and ranged from 16-80. The 
reports, according to the mean age of salivary gland 
neoplasms in the literature, were those of Al-Khateeb 
et al. (9) [40 years], Li et al. (1) [41.38 years], Subhashraj 
(6) [46 years], Vargas et al. (11) [48 years], and Kam-
ulegeya et al. (12) [34 years]. There was a slight over-
all male predominance, with a male to female ratio of 
1.15:1.  This finding coincides with some reports (6,8), 
but differs from the majority of studies that showed a 
higher frequency among females (1,9,11,12). 
In benign tumors, basal cell adenoma, and lipoma oc-
curred in one each case. In malignant tumors, there was 
only one case from some of each group, which were 
acinic cell carcinoma, salivary duct carcinoma, and 
polymorphous low-grade adenocarcinoma. Because of 
polimorphous low-grade adenocarcinoma described as 
recently as 1983, earlier reports did not recognize this 
tumor. It was estimated that this tumor may have been 
diagnosed as adenoid cystic carcinoma. In our reports, 
only one case was found. In the literature, although 
some of the articles (14,20) reported high incidence of 
these tumors, several studies (5,11,13) found no cases of 
these tumors.
Conclusion
Although there were some discrepancies, the patients 
who presented salivary gland neoplasms to the Pathol-
ogy Department of Cumhuriyet University (1987-2008) 
showed that many clinical characteristic of the disease 
were in agreement with most of studies. Discrepancies 
may be explained by the geographic differences, the 
genetic background of the patients, and differences in 
exposure to etiological factors.  
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